NCT01671332 2020-05-12
Docetaxel +/- Suramin in 2nd Line Advanced Non-Small Cell Lung Cancer
University of Wisconsin, Madison
Phase 2 Completed
Clinical Trials
3 trialsNCT01038752 2015-05-21
Evaluation of Non-cytotoxic Suramin as a Chemosensitizer in Non-small Cell Lung Cancer
Optimum Therapeutics, LLC
Phase 2 Terminated
NCT00006929 2013-06-04
Suramin, Paclitaxel, and Carboplatin in Treating Patients With Stage IIIB or Stage IV Non-small Cell Lung Cancer
National Cancer Institute (NCI)
Phase 2 Completed